Pfizer Inc.

Recent Events

News & Analysis

pfizer inc. and strategy - All News and Analysis

• Pharma Roundup: Pfizer and Wyeth, GlaxoSmithKline Overseas, and More

  BNET - 2009-01-23

  Pfizer and Wyeth: ramifications for the industry -- In a much-reported bit of news, Pfizer and Wyeth have been in merger talks for month, although there's no reason to believe the deal will necessarily go through. BNET's Jim Edwards has the details on what that would mean for the two...

  Tags: Wyeth, Pfizer Inc., Genentech Inc., GlaxoSmithKline Plc., Strategy, Management, John Maas

• Pharma Roundup: Generics at Pfizer, Risk-taking at Lilly, and More

  BNET - 2008-10-16

  Pfizer boosting production of generics; CEO says Lilly takes bets "every day"; three new major blood clot treatments in late-stage trials; BMS decreasing international ops? by John Maas

  Tags: Pfizer Inc., Generic, John Maas, Research & Development, Mergers & Acquisitions, Healthcare, Marketing Research, Strategy, Financial Services, Business Operations, Investment, Finance, Marketing, Management

• Pfizer and Chantix: From Bad to Worse

  BNET - 2008-06-17

  Much as I suspected when I first wrote about Pfizer's attempts to minimize potentially serious neurological side effects of its smoking-cessation drug Chantix, the drugmaker's stonewalling tactics have simply made a bad situation worse. To wit: John Spangler, director of Tobacco Intervention Programs at Wake Forest University,...

  Tags: Chantix, David P. Hamilton, Federal Government, Government, Management, Pfizer Inc., Sales, Sales Strategy, Strategy

• Pfizer Leads in Layoffs While Drug Prices Soar

  BNET - 2008-04-10

  Big Pharma continues to lend new meaning to the phrase "doing more with less," because while the industry seems to get smaller every day, drugmakers are still pushing through big price increases on their leading products. Over at Pharmalot, Ed Silverman provides a helpful roundup tracking the...

  Tags: David P. Hamilton, Drug, Drug Company, Job, Layoff, Management, Pfizer Inc., Sales, Sales Strategy, Strategy

• Pfizer Names William Ringo Senior Vice President of Strategy and Business Development

  - 2008-03-03

  NEW YORK -- Pfizer Inc today named William Ringo as the company's new Senior Vice President of Strategy and Business Development with responsibility for guiding Pfizer's overall strategic planning and business development activities, reporting to Chairman and Chief Executive Officer Jeff Kindler. He will join Pfizer's Executive Leadership Team.

  Tags: business development, Pfizer Inc., strategy

• Pfizer, Novartis, Wyeth, GSK, Bayer to Discuss Latest Tactics and Strategies to Improve Patient Compliance and Communication.

  - 2008-01-11

  LONDON, January 11 /PRNewswire/ -- eyeforpharma, the global source of information and education for the pharmaceutical industry, announced today that the 5th annual Patient Compliance & Communication conference, London, 11-12 June 2008 has se LONDON, January 11 /PRNewswire/ -- ...

  Tags: Bayer AG, Novartis AG, patient, Pfizer Inc., strategy, Wyeth

• Charles F. (Chuck) Williams Joins Clarkston Consulting

  - 2007-09-25

  Clarkston Consulting, a leading management and technology consulting firm, announced that Chuck Williams has joined the firm as an Partner in the New York Office. Mr. Williams brings over 29 years of experience in developing information technology strategy, systems and processes in the consumer products, pharmaceutical, and entertainment industries....

  Tags: Clarkston Consulting, Georgia-Pacific Corp., Leadership, Pfizer Inc., Strategy

• Pfizer Proves It Can Do More with Lipitor - Protecting Vital Access to Patients at the Heart of Winning Managed Care Strategy

  - 2007-08-30

  FEASTERVILLE, Pa. -- With Lipitor's formulary access constricting due to generic competition and looming patent expiration, Pfizer aims to extend the health of its flagship cholesterol reducer with an aggressive promotional regimen rivaling that of a new drug in its launch phase. During the first half of 2007 Lipitor was...

  Tags: Lipitor, Microsoft Access, patient, Pfizer Inc., strategy

• National Committee for Quality Assurance and Pfizer Inc Publish Strategies for Optimizing Care for Older Adults; Fourth Edition of Quality Profiles™: The Leadership Series Highlights Successful Efforts to Improve the Quality of Care for Older Adults

  - 2006-06-05

  WASHINGTON -- The National Committee for Quality Assurance NCQA, in collaboration with Pfizer Inc, today released a new publication profiling strategies and recommendations for improving the quality of care for older adults.

  Tags: leadership, Pfizer Inc., QA, strategy

• The Best We've Got

  - 2006-03-01

  In an effort to shore up the United States' international image, Karen Hughes, Bush confidante and State Department public relations czarina, has hit on a new strategy to boost global goodwill: when all else fails, send in the CEOs. According to the Wall Street Journal, Hughes has enlisted corporate CEOs,...

  Tags: antibiotics, CEO, Government, MARKETING, Pfizer Inc., Strategy, U.S., U.S. Department of State